Ophthalmology, Retina Specialist · Ft Myers, FL
NPI
1790744746
Since 2006
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6901 International Center Blvd
Ft Myers, FL, 33912
Phone (239) 939-4323
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.7M
77,966 services
Medicare patients, 2024
1,352
Average age 81
Drug cost, 2024
$766K
443 prescriptions
Company payments, 2025
$364
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul A Raskauskas was code J2777 (injection, faricimab-svoa, 0.1 mg), 57,600 times for 199 patients. In total Paul A Raskauskas billed 77,966 services in 29 codes, and Medicare paid $5.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 57,600 | 199 | $27.60 | $1.6M |
| J0177 Injection, aflibercept hd, 1 mg | Office | 5,992 | 195 | $264.09 | $1.6M |
| 92134 Computerized Ophthalmic Imaging | Office | 3,719 | 1,249 | $30.96 | $115K |
| 67028 Intravitreal Injection | Office | 3,556 | 691 | $91.52 | $325K |
| J0178 Injection, aflibercept, 1 mg | Office | 2,332 | 378 | $660.60 | $1.5M |
| 99213 Office E&M - Established | Office | 1,667 | 703 | $72.81 | $121K |
| 99214 Office E&M - Established | Office | 807 | 743 | $95.05 | $77K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 681 | 19 | $85.87 | $58K |
| J2778 Injection, ranibizumab, 0.1 mg | Office | 605 | 34 | $132.74 | $80K |
| J7999 Compounded drug, not otherwise classified | Office | 527 | 167 | $63.38 | $33K |
| 99204 Office E&M - New | Office | 145 | 145 | $121.77 | $18K |
| 92250 Angiography | Office | 137 | 129 | $27.23 | $3,731 |
| J3490 Unclassified drugs | Office | 64 | 42 | $1,683.17 | $108K |
| 76512 Ultrasound - Nonspecific | Office | 22 | 19 | $40.95 | $901 |
| 92235 Angiography | Office | 14 | 14 | $131.38 | $1,839 |
By year: 2022 $5.1M for 30,292 services; 2023 $5.2M for 64,606 services; 2024 $5.7M for 77,966 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul A Raskauskas prescribed most often to Medicare patients was Eylea (Aflibercept), with 172 prescriptions and refills. In total Paul A Raskauskas wrote 443 Medicare prescriptions that cost $766K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 172 | 202 | 56 | $387K |
| Vabysmo Faricimab-Svoa | 81 | 98 | 25 | $181K |
| Eylea Hd Aflibercept | 50 | 56 | 16 | $142K |
| Prednisolone Acetate Generic | 45 | 76 | 29 | $2,145 |
| Ketorolac Tromethamine Generic | 24 | 45 | 11 | $1,098 |
| Lucentis Ranibizumab | 21 | 28 | Under 11 | $41K |
Brand drugs: 388 claims; generic drugs: 55 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul A Raskauskas $364 ($364 in general payments such as food, travel and fees) from 6 companies. The largest payer was Astellas Pharma US Inc with $173.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.